Israel-based LycoRed has received a US patent for the atherosclerosis-inhibiting properties of its tomato extract, which the firm says adds to the network of support for its ingredient’s heart health benefits.
The patent (US 7,351,746 B2) is based on research conducted on phytoene and phytofluene, which are carotenoids found in natural tomato extract.
According to the company’s vice president of new product development and scientific affairs, Dr Zohar Nir, this research has demonstrated phytoene and phytofluene block the progression of atherosclerosis by inhibiting the deposition of plaque from oxidized LDL-cholesterol.
This effect was demonstrated through in vitro tests on the two compounds alone, together, and in combination with other natural tomato extract carotenoids, he said.
Dr Nir explained that although the patent was “significant” in protecting the company’s intellectual property, this particular sector of heart health is not one that the company will focus on for the time being.
WELL isn't this just another Great reason to GROW YOUR own Tomatoes, Eat them regularly and be sure you put up TONS of Sauce.
There has been a controversy for quite a while about the "Health Benefits" of Lycopene and Tomatoes. It now seems the esteemed is at least recognizing the possible Benefits of Lycopene and Tomatoes. A spokesman for Lyco-Red, Dr Zohar Nir, feels the firm is working toward receiving botanical drug status for its product. This, he explained, would be “an official endorsement from FDA (the US Food and Drug Administration) of the efficacy of the product”, and would help promote the product’s success in the dietary supplement and functional food fields.
This will be great...
But those of us who enjoy Growing Tomatoes for Health and Wealth already knew the benefits and can feel more assured of the Economy of Involving in Sustainable Gardening
Improve our Health through Diet and Exercise, and enjoy the cash flow of selling the surplus.
Catch my Friend Gene's Blog about his production from Straw Bale Tomato Gardening
No comments:
Post a Comment